Upadacitinib vs. dupilumab in adults with moderate-to-severe atopic dermatitis: analysis of the Heads Up phase III trial

被引：0
|
作者：
Blauvelt, A. [1 ]
Teixeira, H. D. [2 ]
Simpson, E. L. [3 ]
Costanzo, A. [4 ,5 ]
De Bruin-Weller, M. [6 ]
Barbarot, S. [7 ]
Prajapati, V. H. [8 ,9 ,10 ,11 ,12 ,13 ]
Lio, P. [14 ,15 ]
Hu, X. [2 ]
Wu, T. [2 ]
Liu, J. [2 ]
Ladizinski, B. [2 ]
Chu, A. D. [2 ]
Eyerich, K. [16 ,17 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR USA
[2] AbbVie Inc, N Chicago, IL USA
[3] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA
[4] Humanitas Univ, Dept Biomed Sci, Dermatol Unit, Pieve Emanuele, Italy
[5] IRCCS, Humanitas Clin & Res Ctr, Rozzano, Italy
[6] Univ Med Ctr Utrecht, Dept Dermatol & Allergol, Utrecht, Netherlands
[7] Nantes Univ, CHU Nantes, Dept Dermatol, Nantes, France
[8] Univ Calgary, Dept Med, Div Dermatol, Calgary, AB, Canada
[9] Univ Calgary, Dept Pediat, Div Community Pediat, Calgary, AB, Canada
[10] Univ Calgary, Dept Pediat, Div Pediat Rheumatol, Calgary, AB, Canada
[11] Skin Hlth & Wellness Ctr, Calgary, AB, Canada
[12] Dermatol Res Inst, Calgary, AB, Canada
[13] Prob Med Res, Calgary, AB, Canada
[14] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA
[15] Med Dermatol Associates Chicago, Chicago, IL USA
[16] Karolinska Inst, Stockholm, Sweden
[17] Karolinska Univ Hosp, Stockholm, Sweden
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 185卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
489
引用
收藏
页码：E123 / E123
页数：1
相关论文
共 50 条
  • [21] Rapid skin clearance and itch improvement with upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: results from a phase 3b head-to-head clinical trial (Heads Up)
    Simpson, Eric L.
    Costanzo, Antonio
    Prajapati, Vimal H.
    Calimlim, Brian M.
    Chu, Alvina D.
    Wu, Tianshuang
    Eyerich, Kilian
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II30 - II31
  • [22] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Xu, Xinghua
    Zheng, Yi
    Zhang, Xin
    He, Yanling
    Li, Chengxin
    ONCOTARGET, 2017, 8 (65) : 108480 - 108491
  • [23] Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
    Andreas Kuznik
    Gaëlle Bégo-Le-Bagousse
    Laurent Eckert
    Abhijit Gadkari
    Eric Simpson
    Christopher N. Graham
    LaStella Miles
    Vera Mastey
    Puneet Mahajan
    Sean D. Sullivan
    Dermatology and Therapy, 2017, 7 : 493 - 505
  • [24] A study into the drug dupilumab in Japanese adults with moderate-to-severe atopic dermatitis
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (01) : E4 - E4
  • [25] Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
    Kuznik, Andreas
    Bego-Le-Bagousse, Gaelle
    Eckert, Laurent
    Gadkari, Abhijit
    Simpson, Eric
    Graham, Christopher N.
    Miles, LaStella
    Mastey, Vera
    Mahajan, Puneet
    Sullivan, Sean D.
    DERMATOLOGY AND THERAPY, 2017, 7 (04) : 493 - 505
  • [26] Dupilumab Treatment Reduces Hospitalizations in Adults With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan, I
    Rubini, Norma P. M.
    Pires, Mario C.
    Rossi, Ana B.
    Zhang, Annie
    Chen, Zhen
    Levit, Noah A.
    Chao, Jingdong
    Shumel, Brad
    Bego-Le Bagousse, Gaelle
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (05): : 1279 - +
  • [27] Efficacy and safety of abrocitinib and upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
    Gao, Qin
    Zhao, Yanxia
    Zhang, Junling
    HELIYON, 2023, 9 (06)
  • [28] Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies
    Guttman-Yassky, Emma
    Thyssen, Jacob P.
    Silverberg, Jonathan I.
    Papp, Kim A.
    Paller, Amy S.
    Weidinger, Stephan
    Hong, H. Chih-ho
    Hendrickson, Barbara
    Dilley, Deanne
    Tenorio, Allan R.
    Ladizinski, Barry
    Chu, Alvina D.
    Liu, John
    Irvine, Alan D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (01) : 172 - 181
  • [29] Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: A meta-analysis
    Ou, Zuzhen
    Chen, Chao
    Chen, Aijun
    Yang, Yao
    Zhou, Weikang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 54 : 303 - 310
  • [30] Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis and a history of nonsteroidal immunosuppressant use: a post hoc analysis of the phase III CAFE trial
    Bouaziz, J. -D.
    Ogg, G.
    de Bruin-Weller, M.
    Bieber, T.
    Irvine, A.
    Shumel, B.
    Msihid, J.
    Rossi, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 66 - 67
12345